stoxline Quote Chart Rank Option Currency Glossary
Quest Diagnostics Incorporated (DGX)
134.89  -2.6 (-1.89%)    12-05 16:00
Open: 137.27
High: 137.27
Volume: 703,019
Pre. Close: 137.49
Low: 134.84
Market Cap: 15,166(M)
Technical analysis
2023-12-05 4:19:29 PM
Short term     
Mid term     
Targets 6-month :  160.72 1-year :  187.73
Resists First :  137.61 Second :  160.72
Pivot price 135.43
Supports First :  131.98 Second :  128.5
MAs MA(5) :  136.2 MA(20) :  134.73
MA(100) :  130.92 MA(250) :  137.44
MACD MACD :  1.8 Signal :  2
%K %D K(14,3) :  76.9 D(3) :  84.3
RSI RSI(14): 54.8
52-week High :  158.33 Low :  119.58
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ DGX ] has closed above bottom band by 35.2%. Bollinger Bands are 55% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 137.74 - 138.41 138.41 - 138.98
Low: 134.24 - 135.02 135.02 - 135.69
Close: 136.33 - 137.53 137.53 - 138.57
Company Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Headline News

Tue, 05 Dec 2023
Quest Diagnostics Inc. stock falls Tuesday, underperforms market - MarketWatch

Tue, 05 Dec 2023
Panagora Asset Management Inc. Reduces Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Mon, 04 Dec 2023
Quest Diagnostics Inc. stock outperforms market on strong trading day - MarketWatch

Mon, 04 Dec 2023
Quest Diagnostics Inc (DGX) Stock Has Risen 0.95% This Week: Buy, Hold, or Sell? - InvestorsObserver

Mon, 04 Dec 2023
Zacks Research Weighs in on Quest Diagnostics Incorporated's Q4 2024 Earnings (NYSE:DGX) - MarketBeat

Fri, 01 Dec 2023
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Diagnostics & Research
Shares Out 112 (M)
Shares Float 111 (M)
Held by Insiders 0.8 (%)
Held by Institutions 92.8 (%)
Shares Short 2,690 (K)
Shares Short P.Month 2,970 (K)
Stock Financials
EPS 6.71
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 57.36
Profit Margin 8.2 %
Operating Margin 15.3 %
Return on Assets (ttm) 5.8 %
Return on Equity (ttm) 12.7 %
Qtrly Rev. Growth -7.7 %
Gross Profit (p.s.) 30.86
Sales Per Share 82.71
EBITDA (p.s.) 15.11
Qtrly Earnings Growth -9.7 %
Operating Cash Flow 1,080 (M)
Levered Free Cash Flow 406 (M)
Stock Valuations
PE Ratio 20.1
PEG Ratio -27.7
Price to Book value 2.35
Price to Sales 1.63
Price to Cash Flow 14.04
Stock Dividends
Dividend 0.7
Forward Dividend 0
Dividend Yield 0.5%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android